Millennium Management
DYN icon

Millennium Management’s Dyne Therapeutics DYN Stock Holding History

Millennium Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.59M Buy
431,850
+273,302
+172% +$5.08M ﹤0.01% 2317
2026
Q1 		$2.87M Sell
158,548
-745,841
-82% -$12.9M ﹤0.01% 3513
2025
Q4 		$17.7M Buy
904,389
+490,449
+118% +$9.29M 0.01% 1697
2025
Q3 		$5.24M Buy
413,940
+271,221
+190% +$3.09M ﹤0.01% 3103
2025
Q2 		$1.36M Buy
142,719
+64,540
+83% +$711K ﹤0.01% 4195
2025
Q1 		$818K Buy
78,179
+40,643
+108% +$581K ﹤0.01% 4499
2024
Q4 		$884K Buy
37,536
+31,545
+527% +$933K ﹤0.01% 4299
2024
Q3 		$215K Buy
+5,991
New +$238K ﹤0.01% 5409
2024
Q2 		– Sell
-18,011
Closed -$511K – 6016
2024
Q1 		$511K Sell
18,011
-370,079
-95% -$8.37M ﹤0.01% 4801
2023
Q4 		$5.16M Buy
+388,090
New +$3.79M ﹤0.01% 2764
2023
Q2 		– Sell
-190,363
Closed -$2.19M – 6211
2023
Q1 		$2.19M Sell
190,363
-63,747
-25% -$828K ﹤0.01% 3356
2022
Q4 		$2.94M Buy
254,110
+172,159
+210% +$1.99M ﹤0.01% 3230
2022
Q3 		$1.04M Buy
+81,951
New +$940K ﹤0.01% 4308
2021
Q1 		– Sell
-38,590
Closed -$810K – 6042
2020
Q4 		$810K Sell
38,590
-155,475
-80% -$3.08M ﹤0.01% 3868
2020
Q3 		$3.92M Buy
+194,065
New +$4.26M ﹤0.01% 2058

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Millennium Management's DYN Position: Q2 2026 in Review

Millennium Management increased its Dyne Therapeutics (DYN) stake by 172% in Q2 2026, buying an estimated $5.08M and bringing the position to 431,850 shares worth $9.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Millennium Management first reported a position in DYN in Q3 2020 and has held it in 15 quarters since. The position peaked at $17.7M in Q4 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Millennium Management held 431,850 shares of Dyne Therapeutics worth $9.59M as of Q2 2026.
  • Millennium Management bought 273,302 Dyne Therapeutics shares in Q2 2026, an estimated $5.08M.
  • Dyne Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2317 holding.
  • Millennium Management first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 15 quarters since.
  • Millennium Management's Dyne Therapeutics position peaked at $17.7M in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.